Based on the differences observed between in vivo and in vitro experiments, as well as previous reported CRISPR screening result, we hypothesized that the inhibitory effect Sin3B loss on pancreatic cancer might rely on anti‐tumor immunity. The gene discussed is SIN3B; the disease is familial pancreatic carcinoma.